Sexuality after sigmoid colpopoiesis in patients with Mayer-Rokitansky-Kuster-Hauser Syndrome.
OBJECTIVE
To assess the functional outcome and sexuality of patients after creation of a sigmoid neovagina.


METHODS
Clinical study performed between 1992 and 2002, with a mean follow-up of 3.3 years (range, 6 months to 9 years).


METHODS
Tertiary care center.


METHODS
Sixteen consecutive patients with Rokitansky syndrome.


METHODS
Creation of a neovagina with an antiperistaltic (n = 13) or isoperistaltic (n = 3) sigmoid graft and colovestibular anastomosis by interrupted suture (n = 11) or PCEEA forceps (n = 5). All patients had a neovaginal vault suspension (n = 16).


METHODS
Functional results were evaluated in patients 6 or more months after the operation (n = 12) by using the standardized Female Sexual Function Index (FSFI). This index assesses four domains of sexual dysfunction: desire disorder, arousal disorder, orgasm disorder, and sexual pain disorder. Lubrification and "sexual" quality of life was also evaluated. Normal patients had a mean full FSFI score of 30 +/- 5 of 36.


RESULTS
The mean full FSFI score was 28 +/- 5 (range: 22-34). Seventy-two percent of patients had vaginal intercourse at least once a week; in this subset, the mean full FSFI score was 30 +/- 3 (range: 25-34).


CONCLUSIONS
Sigmoid neovagina allowed a normal sexual life in patients who had sexual relations.
Communal
Pierre-Henri
PH
Department of Obstetrics and Gynecology, Centre Hospitalo-Universitaire Hôtel-Dieu, Lyon, France.
Chevret-Measson
Marie
M
Golfier
Francois
F
Raudrant
Daniel
D
D000293:Adolescent; D000328:Adult; D001007:Anxiety / Q000209:etiology; D001826:Body Fluids / Q000378:metabolism; D012809:Colon, Sigmoid / Q000637:transplantation*; D004414:Dyspareunia / Q000209:etiology / Q000503:physiopathology; D005260:Female; D006801:Humans; D007247:Infertility, Female / Q000523:psychology; D007989:Libido; D009948:Orgasm; D012649:Self Concept; D019529:Sexuality; D019738:Surgically-Created Structures / Q000009:adverse effects; D011795:Surveys and Questionnaires; D013577:Syndrome; D016896:Treatment Outcome; D014599:Uterus / Q000002:abnormalities*; D014621:Vagina / Q000002:abnormalities* / Q000378:metabolism / Q000601:surgery*